BioMS Medical's lead technology, MBP8298, is for the treatment of multiple sclerosis and it has two pivotal phase III
clinical trials for SPMS patients, MAESTRO-01 in Canada and Europe and MAESTRO-03 in the United States.
The Phase III
program for Crohn's Disease will consist of two double-blind, placebo-controlled trials.
I am pleased that we have now established and demonstrated consistent production and processes to support our Phase III
trial of ALTU-135.
The agreement which involves both process development and manufacturing of the biopharmaceutical drug substance for this clinical phase III
trial, means that we will utilize our extensive expertise and broad experience in protein pharmaceuticals to the full extent," says Hans EurstrEm, SVP Biovitrum Biopharmaceuticals and Marketing & Sales.
The product was originally developed by Ciba-Geigy and IDM completed the development of the product manufacturing and performed the required analyses including the Phase III
analyses for the FDA submission.
We are pleased to initiate this Phase III
clinical study of Probuphine in the treatment of opioid dependence," stated Dr.
NASDAQ:OSIR) has received manufacturing authorization to distribute PROCHYMAL into Europe for its Phase III
The upfront payment will add sufficient cash on our balance sheet to last through the first quarter of 2008, which is beyond the time when we expect to see data from both of our pivotal Phase III
Wayne Marasco, MD, PhD, Senior Scientific Advisor of Phase III
Medical said, "Dr.
NASDAQ: ALTU), a biopharmaceutical company focused on the development and commercialization of oral and injectable protein therapeutics for patients with gastrointestinal and metabolic diseases, today provided an update on its plans for initiation of Phase III
clinical trials for ALTU-135 and ALTU-238.
NASDAQ: IDEV) today announced data from the second of two Phase III
clinical trials with SANCTURA XR for overactive bladder (OAB).
OTC BB: CLSC), a pharmaceutical development company focused on the treatment of allergy and other atopic conditions, today announced it intends to initiate two identical, Phase III
Clinical Trials of its anti-allergy medication PreHistin(R) in patients with seasonal allergic rhinitis.